Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review

Saudi Journal of Ophthalmology

Volumn 29, Issue 3, 2015, Pages 212-221

  Al Arfaj, Khalid ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

B KPro; Boston keratoprosthesis; Corneal transplantation; Keratoprosthesis implantation; KPro

Indexed keywords

CHLORAMPHENICOL; QUINOLONE DERIVATIVE; VANCOMYCIN;

BANDAGE CONTACT LENS; BLINDNESS; CLIMATE; CORNEA; CORNEA DISEASE; CORNEA TRANSPLANTATION; ENDOPHTHALMITIS; GEOGRAPHY; HUMAN; KERATOPROSTHESIS; PENETRATING KERATOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; VISUAL ACUITY; VITREORETINOPATHY;

EID: 84937635949     PISSN: 13194534     EISSN: 25426680     Source Type: Journal    
DOI: 10.1016/j.sjopt.2015.02.001     Document Type: Review

References (71)

1. Kim M.J., Bakhtiari P., Aldave A.J. The international use of the Boston type I keratoprosthesis. Int Ophthalmol Clin 2013, 53:79-89.
2. Oliva M.S., Schottman T., Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol 2012, 60:423-427.
3. Whitcher J.P., Srinivasan M., Upadhyay M.P. Corneal blindness: a global perspective. Bull World Health Organ 2001, 79:214-221.
4. Lam F.C., Liu C. The future of keratoprostheses (artificial corneae). Br J Ophthalmol 2011, 95:304-305.
5. Shihadeh W.A., Mohidat H.M. Outcomes of the Boston keratoprosthesis in jordan. Middle East Afr J Ophthalmol 2012, 19:97-100.
6. Aquavella J.V., Qian Y., McCormick G.J., Palakuru J.R. Keratoprosthesis: the Dohlman-Doane device. Am J Ophthalmol 2005, 140:1032-1038.
7. Akpek E.K., Harissi-Dagher M., Petrarca R., Butrus S.I., Pineda R., Aquavella J.V., et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol 2007, 144:227-231.
8. Sayegh R.R., Ang L.P., Foster C.S., Dohlman C.H. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol 2008, 145:438-444.
9. Bradley J.C., Hernandez E.G., Schwab I.R., Mannis M.J. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 2009, 28:321-327.
10. Chew H.F., Ayres B.D., Hammersmith K.M., Rapuano C.J., Laibson P.R., Myers J.S., et al. Boston keratoprosthesis outcomes and complications. Cornea 2009, 28:989-996.
11. Greiner M.A., Li J.Y., Mannis M.J. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 2011, 118:1543-1550.
12. Robert M.C., Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol 2011, 46:164-168.
13. Li J.Y., Greiner M.A., Brandt J.D., Lim M.C., Mannis M.J. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol 2011, 152:209-218.
14. Traish A.S., Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol 2010, 25:239-243.
15. Al Arfaj K., Hantera M. Short-term visual outcomes of Boston keratoprosthesis type I in Saudi Arabia. Middle East Afr J Ophthalmol 2012, 19:88-92.
16. Aldave A.J., Sangwan V.S., Basu S., Basak S.K., Hovakimyan A., Gevorgyan O., et al. International results with the Boston type I keratoprosthesis. Ophthalmology 2012, 119:1530-1538.
17. Jasinskas V., Rudalevicius P., Miliauskas A., Milcius D., Jurkunas U.V. Keratoprosthesis surgery as an alternative to keratoplasty. Medicina (Kaunas) 2013, 49:291-299.
18. Khan B., Dudenhoefer E.J., Dohlman C.H. Keratoprosthesis: an update. Curr Opin Ophthalmol 2001, 12:282-287.
19. Gomaa A., Comyn O., Liu C. Keratoprostheses in clinical practice - a review. Clin Experiment Ophthalmol 2010, 38:211-224.
20. Ilhan-Sarac O., Akpek E.K. Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol 2005, 16:246-250.
21. Cruzat A., Tauber A., Shukla A., Paschalis E.I., Pineda R., Dohlman C.H. Low-cost and readily available tissue carriers for the Boston keratoprosthesis: a review of possibilities. J Ophthalmol 2013, 2013:686587.
22. de laPaz M.F., Stoiber J., de Rezende Couto Nascimento V., de Toledo J.A., Seyeddain O., Hitzl W., et al. Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases. Graefes Arch Clin Exp Ophthalmol 2014, 252:83-90.
23. Dohlman C., Harissi-Dagher M., Graney J. The Boston keratoprosthesis: a new threadless design. Digit J Opthalmol 2007, 13:1-6.
24. Dohlman C.H., Dudenhoefer E.J., Khan B.F., Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J 2002, 28:72-74.
25. Dudenhoefer E.J., Nouri M., Gipson I.K., Baratz K.H., Tisdale A.S., Dryja T.P., et al. Histopathology of explanted collar button keratoprostheses: a clinicopathologic correlation. Cornea 2003, 22:424-428.
26. Sayegh R.R., Avena Diaz L., Vargas-Martin F., Webb R.H., Dohlman C.H., Peli E. Optical functional properties of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci 2010, 51:857-863.
27. Khan B.F., Harissi-Dagher M., Khan D.M., Dohlman C.H. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 2007, 47:61-71.
28. Traish A.S., Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol 2010, 25:239-243.
29. Todani A., Ciolino J.B., Ament J.D., Colby K.A., Pineda R., Belin M.W., et al. Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol 2011, 249:1515-1518.
30. Ament J.D., Spurr-Michaud S.J., Dohlman C.H., Gipson I.K. The Boston keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea 2009, 28:808-811.
31. Zerbe B.L., Belin M.W., Ciolino J.B. Boston type 1 keratoprosthesis study G. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology 2006, 113. 1779 e1-e7.
32. Rudnisky C.J., Belin M.W., Todani A., Al-Arfaj K., Ament J.D., Zerbe B.J., et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2012, 119:951-955.
33. Ciolino J.B., Belin M.W., Todani A., Al-Arfaj K., Rudnisky C.J. Boston keratoprosthesis type 1 study G. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013, 120:1195-1200.
34. Aldave A.J., Kamal K.M., Vo R.C., Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009, 116:640-651.
35. Sejpal K., Yu F., Aldave A.J. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea 2011, 30:1187-1194.
36. Pineles S.L., Ela-Dalman N., Rosenbaum A.L., Aldave A.J., Velez F.G. Binocular visual function in patients with Boston type I keratoprostheses. Cornea 2010, 29:1397-1400.
37. Yaghouti F., Nouri M., Abad J.C., Power W.J., Doane M.G., Dohlman C.H. Keratoprosthesis: preoperative prognostic categories. Cornea 2001, 20:19-23.
38. Ciolino J.B., Dohlman C.H. Biologic keratoprosthesis materials. Int Ophthalmol Clin 2009, 49:1-9.
39. Nallasamy S., Colby K. Keratoprosthesis: procedure of choice for corneal opacities in children?. Semin Ophthalmol 2010, 25:244-248.
40. Colby K.A., Koo E.B. Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol 2011, 22:267-273.
41. Patel A.P., Wu E.I., Ritterband D.C., Seedor J.A. Boston type 1 keratoprosthesis: the New York eye and ear experience. Eye (Lond) 2012, 26:418-425.
42. Al Arfaj K. Four-year outcomes and complications of Boston keratoprosthesis type I implantation in the Middle East. Spektrum der Augenheilkunde 2014: e-pub (ahead of print).
43. de Oliveira L.A., Pedreira Magalhaes F., Hirai F.E., deSousa L.B. Experience with Boston keratoprosthesis type 1 in the developing world. Can J Ophthalmol 2014, 49:351-357.
44. Qian C.X., Hassanaly S., Harissi-Dagher M. Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston type I keratoprosthesis. Ophthalmology 2014.
45. Lekhanont K., Thaweesit P., Muntham D., Chuckpaiwong V., Vongthongsri A. Medium-term outcomes of Boston type 1 keratoprosthesis implantation in Bangkok, Thailand. Cornea 2014, 33:1312-1319.
46. Srikumaran D., Munoz B., Aldave A.J., Aquavella J.V., Hannush S.B., Schultze R., et al. Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology 2014, 121:2159-2164.
47. Phillips D.L., Hager J.L., Goins K.M., Kitzmann A.S., Greiner M.A., Cohen A.W., et al. Boston type 1 keratoprosthesis for chemical and thermal injury. Cornea 2014, 33:905-909.
48. Hassanaly S.I., Talajic J.C., Harissi-Dagher M. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol 2014, 158(270-6):e1.
49. Brown C.R., Wagoner M.D., Welder J.D., Cohen A.W., Goins K.M., Greiner M.A., et al. Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy. Cornea 2014, 33:801-805.
50. Ciolino J.B., Belin M.W., Todani A., Al-Arfaj K., Rudnisky C.J. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013, 120:1195-1200.
51. Verdejo-Gomez L., Pelaez N., Gris O., Guell J.L. The Boston type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surg Lasers Imaging 2011, 42:446-452.
52. Klufas M.A., Colby K.A. The Boston keratoprosthesis. Int Ophthalmol Clin 2010, 50:161-175.
53. Robert M.C., Moussally K., Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol 2012, 96:776-780.
54. Ramchandran R.S., Diloreto D.A., Chung M.M., Kleinman D.M., Plotnik R.P., Graman P., et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology 2012, 119:674-681.
55. Behlau I., Martin K.V., Martin J.N., Naumova E.N., Cadorette J.J., Sforza J.T., et al. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol 2014.
56. Crnej A., Paschalis E.I., Salvador-Culla B., Tauber A., Drnovsek-Olup B., Shen L.Q., et al. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea 2014, 33:349-354.
57. Kamyar R., Weizer J.S., de Paula F.H., Stein J.D., Moroi S.E., John D., et al. Glaucoma associated with Boston type I keratoprosthesis. Cornea 2012, 31:134-139.
58. Sivaraman K.R., Hou J.H., Allemann N., de la Cruz J., Cortina M.S. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston Keratoprosthesis. Am J Ophthalmol 2013, 155:814-822.
59. Harissi-Dagher M., Khan B.F., Schaumberg D.A., Dohlman C.H. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea 2007, 26:564-568.
60. Ciralsky J., Papaliodis G.N., Foster C.S., Dohlman C.H., Chodosh J. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm 2010, 18:275-280.
61. Tay E., Utine C.A., Akpek E.K. Crescenteric amniotic membrane grafting in keratoprosthesis-associated corneal melt. Arch Ophthalmol 2010, 128:779-782.
62. Harissi-Dagher M., Durr G.M., Biernacki K., Sebag M., Rheaume M.A. Pars plana vitrectomy through the Boston Keratoprosthesis type 1. Eye (Lond) 2013, 27:767-769.
63. Ray S., Khan B.F., Dohlman C.H., D'Amico D.J. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol 2002, 120:559-566.
64. Magalhaes F.P., Sousa L.B., Oliveira L.A. Boston type I keratoprosthesis: review. Arq Bras Oftalmol 2012, 75:218-222.
65. Chan C.C., Holland E.J. Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea 2012, 31:1128-1134.
66. Chhablani J., Panchal B., Das T., Pathegay A., Motukupally S.R., Pappuru R.R., et al. Endophthalmitis in Boston keratoprosthesis: case series and review of literature. Int Ophthalmol 2014.
67. Ciolino J.B., Stefanescu C.F., Ross A.E., Salvador-Culla B., Cortez P., Ford E.M., et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials 2014, 35:432-439.
68. Kanellopoulos A.J., Asimellis G. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1. Cornea 2014, 33:914-918.
69. Dohlman J.G., Foster C.S., Dohlman C. Boston keratoprosthesis in Stevens-Johnson syndrome: a case of using infliximab to prevent tissue necrosis. Digit J Opthalmol 2009, 15:1-6.
70. Fadlallah A., Atallah M., Cherfan G., Awwad S.T., Syed Z.A., Melki S.A. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting. Cornea 2014, 33:235-239.
71. Robert M.C., Biernacki K., Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea 2012, 31:339-345.